Type 2 diabetes risk factors were predominant for diabetes occurring before chronic pancreatitis
THURSDAY, Dec. 1, 2022 (HealthDay News) — Predictors of diabetes arising from chronic pancreatitis (CP) have been identified and include type 2 diabetes risk factors and pancreatic disease-related risk factors, according to a study published online Nov. 16 in Diabetes Care.
Christie Jeon, Sc.D., from the Cedars-Sinai Medical Center in Los Angeles, and colleagues conducted a cross-sectional study involving 645 individuals with CP enrolled in the PROCEED study, 276 of whom had diabetes. Univariable and multivariable analyses of potential risk factors for diabetes were performed.
The researchers found that independent correlates of diabetes in CP included risk factors for type 2 diabetes (older age, overweight/obesity, male sex, non-White race, and tobacco use) and pancreatic disease-related factors, including history of acute pancreatitis complications, nonalcoholic etiology of CP, exocrine pancreatic dysfunction, pancreatic calcification, and pancreatic atrophy (area under the receiver operating characteristic curve, 0.745). For diabetes occurring before pancreatitis, type 2 diabetes risk factors were predominant, while pancreatic disease-related factors were predominant for diabetes that occurred after pancreatitis.
“We anticipate that over time, a sufficient number of incident cases will be available for us to validate the current models or develop new models to predict diabetes in CP,” the authors write. “This would pave the way for diabetes prevention trials in CP.”
One author disclosed financial ties to the pharmaceutical industry; two authors disclosed ties to Nestle.
Abstract/Full Text (subscription or payment may be required)
Weight-Loss Surgery Produces Lasting Diabetes Remission
Spinal Cord Stimulation Cuts Pain, Improves Sensation With Diabetic Nerve Damage
People With ADHD Experience 50 Percent More GI Symptoms
Relapse Rare After Appendiceal Adenocarcinoma Resection
Local Recurrence Rate Low After R0 Resection of Soft Tissue Sarcoma Tumors
Postoperative Complications Elevated for Patients With Systemic Lupus Erythematosus
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement